Boehringer Ingelheim faces second hung jury in Chicago Zantac trial
The latest trial over claims that the discontinued heartburn drug Zantac causes cancer ended with a hung jury on Wednesday, ...
A second Zantac cancer trial ends with hung jury
The latest trial over claims that the discontinued heartburn drug Zantac causes cancer ended with a hung jury on Wednesday, ...
Becker's Hospital Review3d
Zantac cancer trial results in hung jury
A Chicago jury failed to reach a verdict Sept. 18 over claims that heartburn drug Zantac causes cancer, Reuters exclusively reported.
ConsumerAffairs3d
Zantac trial ends with hung jury unable to decide if the popular heartburn drug caused cancer
The FDA in 2020 asked manufacturers to pull the drug off the market over concerns that its active ingredient, ranitidine, could degrade into NDMA, a carcinogen, over time or when exposed to heat.
Yahoo3d
Boehringer Ingelheim faces second hung jury in Chicago Zantac trial
The litigation began after the U.S. Food and Drug Administration in 2020 asked manufacturers to pull the drug off the market over concerns that its active ingredient, ranitidine, could degrade ...
U.S. News & World Report4d
A Second Zantac Cancer Trial Ends With Hung Jury
The litigation began after the U.S. Food and Drug Administration in 2020 asked manufacturers to pull the drug off the market over concerns that its active ingredient, ranitidine, could degrade ...
The Gazette4d
A second Zantac cancer trial ends with hung jury
(Reuters) - The latest trial over claims that the discontinued heartburn drug Zantac causes cancer ended with a hung jury on Wednesday, as jurors in Chicago were unable to agree on whether ...